by John Conrad | Nov 20, 2025 | Member News
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay $105 per share in cash, a 51% premium, sending Exact’s stock sharply higher for a second straight day. The deal gives...
